Latest News and Press Releases

  Lumara Bio brings together ITM's existing pipeline of early- and late-stage radiopharmaceutical therapies, including lead drug candidate 177Lu-edotreotide (ITM-11), into a single, dedicated...

Delray Beach, FL, July 22, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global radiotherapy market will grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0%...

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Radiotherapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The global Radiotherapy Market research report...

Analysis from the Phase 3 COMPETE trial suggests population-based modeling may enable accurate individualized dosimetry with substantially fewer imaging requirements Los Angeles, California, June 1,...

Garching / Munich, May 19, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that dosimetry data from its Phase 3 COMPETE trial will be...

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Image-Guided Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Intraoperative Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

“Immunotherapy Drugs: Global Markets” is expected to grow from $260.7 billion in 2025 to reach $467.4 billion by the end of 2030, at a CAGR of 12.4% .

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Adaptive Radiotherapy Software Market Report 2025" has been added to ResearchAndMarkets.com's offering. Adaptive Radiotherapy Software Global...

BetaGlue Receives Belgium Ministry of Health Approval for YntraDose® Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)